Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: I
Results 101 - 110 of 403 shown below

  • immunochemotherapy

    C M L van Herpen, R L H Jansen, W H J Kruit, K Hoekman, G Groenewegen, S Osanto and P H M De Mulder

    Immunochemotherapy with interleukin-2, interferon- alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

    doi:10.1054/bjoc.1999.0997

  • immunoconjugate

    S Tsunoda, I Ohizumi, J Matsui, K Koizumi, Y Wakai, H Makimoto, Y Tsutsumi, N Utoguchi, K Taniguchi, H Saito, N Harada, Y Ohsugi and T Mayumi

    Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy

    doi:10.1038/sj.bjc.6690823

  • immunoconjugates

    T L Cheng and S R Roffler

    Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug

    doi:10.1038/sj.bjc.6690221

  • Immunocytochemistry

    G Pelosi, U Pastorino, F Pasini, P Maissoneuve, F Fraggetta, A lannucci, A Sonzogni, G De Manzoni, A Terzi, E Durante, E Bresaola, F Pezzella and G Viale

    Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer

    doi:10.1038/sj.bjc.6600731

  • D Vernimmen, M Gueders, S Pisvin, P Delvenne and R Winkler

    Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers

    doi:10.1038/sj.bjc.6601200

  • S Garcia, J-P Dalès, J Jacquemier, E Charafe-Jauffret, D Birnbaum, L Andrac-Meyer, M-N Lavaut, C Allasia, S Carpentier-Meunier, P Bonnier and C Charpin-Taranger

    c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

    doi:10.1038/sj.bjc.6603569

  • G Mukherjee, B Muralidhar, U D Bafna, R A Laskey and N Coleman

    MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India

    advance online publication, 2007-03-06 00:00:00.000;

    doi:10.1038/sj.bjc.6603679

  • M V Corrias, S Parodi, R Haupt, L Lacitignola, F Negri, A R Sementa, D Dau, F Scuderi, B Carlini, M Bianchi, F Casale, L Faulkner and A Garaventa

    Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

    advance online publication, 2008-01-08 00:00:00.000;

    doi:10.1038/sj.bjc.6604179

  • A Mezzelani, L Alasio, C Bartoli, M G Bonora, M A Pierotti, F Rilke and S Pilotti

    c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates

    doi:10.1038/sj.bjc.6690387

  • D Trerè, L Fiume, L Badiali De Giorgi, G Di Stefano, M Migaldi and M Derenzini

    The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells

    doi:10.1038/sj.bjc.6690708

  • G Pelosi, F Pasini, C Ottensmeier, F Pavanel, E Bresaola, A Bonetti, F Fraggetta, A Terzi, A Iannucci and G L Cetto

    Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients

    doi:10.1038/sj.bjc.6690831

  • J Simony-Lafontaine, M Esslimani, E Bribes, S Gourgou, N Lequeux, R Lavail, J Grenier, A Kramar and P Casellas

    Immunocytochemical assessment of sigma-1 receptor and human sterol isomerase in breast cancer and their relationship with a series of prognostic factors

    doi:10.1054/bjoc.2000.1162

  • immunocytochemistry staining

    L Perey, J Benhattar, R Peters, P Jaunin and S Leyvraz

    High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR

    doi:10.1054/bjoc.2001.2177

  • immunocytokine

    C Heuser, M Ganser, A Hombach, H Brand, G Denton, F-G Hanisch and H Abken

    An anti-MUC1-antibody–interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells

    doi:10.1038/sj.bjc.6601267

  • immunocytology

    K Beiske, S A Burchill, I Y Cheung, E Hiyama, R C Seeger, S L Cohn, A D J Pearson and K K Matthay

    Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

    advance online publication, 2009-04-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605029

  • H Nekarda, C Ges zlig, M Stark, U Fink, U Schenck and J R Siewert

    Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma

    doi:10.1038/sj.bjc.6690096

  • immunodeficiency

    L Dal Maso, S Franceschi, A Lo Re and C La Vecchia

    Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe

    doi:10.1038/sj.bjc.6690026

  • immunodetection

    E Schultz-Thater, C Noppen, F Gudat, U Dürmüller, P Zajac, T Kocher, M Heberer and G C Spagnoli

    NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens

    doi:10.1054/bjoc.2000.1251

  • immunofluorescence

    B H Joshi, P Leland, J Silber, R J Kreitman, I Pastan, M Berger and R K Puri

    IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein

    doi:10.1038/sj.bjc.6600034

  • R Tedeschi, T Luostarinen, P De Paoli, R E Gislefoss, L Tenkanen, J Virtamo, P Koskela, G Hallmans, M Lehtinen and J Dillner

    Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk

    advance online publication, 2005-08-30 00:00:00.000;

    doi:10.1038/sj.bjc.6602751